|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,462.00 GBX | -0.78% |
|
-3.44% | +5.89% |
| 07-09 | FTSE 100 held back by AstraZeneca trial setback | AN |
| 07-09 | FTSE 100 misses out on rebound as Astra drops | AN |
Company Valuation: British American Tobacco p.l.c.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 62,725 | 73,164 | 51,201 | 63,430 | 91,543 | 96,419 | - | - |
| Change | - | 16.64% | -30.02% | 23.89% | 44.32% | 5.33% | - | - |
| Enterprise Value (EV) 1 | 99,118 | 112,445 | 85,841 | 94,683 | 122,758 | 126,442 | 125,207 | 124,097 |
| Change | - | 13.45% | -23.66% | 10.3% | 29.65% | 3% | -0.98% | -0.89% |
| P/E | 9.25x | 11.2x | -3.55x | 21.2x | 12.1x | 13.1x | 12.1x | 11.2x |
| PBR | 0.96x | 1x | 0.97x | 1.29x | 2.04x | 2.05x | 2.01x | 1.99x |
| PEG | - | -8.95x | 0x | -0x | 0x | -5.51x | 1.4x | 1.43x |
| Capitalization / Revenue | 2.44x | 2.65x | 1.88x | 2.45x | 3.57x | 3.68x | 3.56x | 3.43x |
| EV / Revenue | 3.86x | 4.07x | 3.15x | 3.66x | 4.79x | 4.83x | 4.62x | 4.42x |
| EV / EBITDA | 8.35x | 8.51x | 6.49x | 7.56x | 10x | 10x | 9.46x | 9.06x |
| EV / EBIT | 8.89x | 9.06x | 6.89x | 7.96x | 10.6x | 10.8x | 10.2x | 9.63x |
| EV / FCF | 10.8x | 11.4x | 8.37x | 9.82x | 21.2x | 16.9x | 15.9x | 15.4x |
| FCF Yield | 9.27% | 8.78% | 11.9% | 10.2% | 4.72% | 5.91% | 6.28% | 6.51% |
| Dividend per Share 2 | 2.156 | 2.309 | 2.355 | 2.402 | 2.45 | 2.513 | 2.594 | 2.703 |
| Rate of return | 7.89% | 7.04% | 10.3% | 8.34% | 5.81% | 5.63% | 5.81% | 6.06% |
| EPS 2 | 2.956 | 2.919 | -6.466 | 1.36 | 3.491 | 3.408 | 3.702 | 3.992 |
| Distribution rate | 72.9% | 79.1% | -36.4% | 177% | 70.2% | 73.7% | 70.1% | 67.7% |
| Net sales 1 | 25,684 | 27,655 | 27,283 | 25,867 | 25,610 | 26,197 | 27,111 | 28,074 |
| EBITDA 1 | 11,874 | 13,208 | 13,223 | 12,524 | 12,240 | 12,621 | 13,229 | 13,704 |
| EBIT 1 | 11,150 | 12,408 | 12,465 | 11,890 | 11,572 | 11,758 | 12,315 | 12,887 |
| Net income 1 | 6,801 | 6,666 | -14,367 | 3,068 | 7,677 | 7,524 | 7,951 | 8,360 |
| Net Debt 1 | 36,393 | 39,281 | 34,640 | 31,253 | 31,215 | 30,023 | 28,788 | 27,678 |
| Reference price 2 | 27.34 | 32.82 | 22.96 | 28.80 | 42.14 | 44.62 | 44.62 | 44.62 |
| Nbr of stocks (in thousands) | 2,294,686 | 2,229,591 | 2,230,487 | 2,202,445 | 2,172,351 | 2,160,886 | - | - |
| Announcement Date | 2/11/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 13.09x | 4.83x | 10.02x | 5.63% | 129B | ||
| 23.07x | 7.46x | 17.02x | 3.34% | 283B | ||
| 10.06x | 2.95x | 6.77x | 6.16% | 27.86B | ||
| 30.33x | 2.04x | 18.57x | 2% | 6.03B | ||
| 60.45x | - | - | 0.37% | 1.7B | ||
| 12x | - | - | - | 1.29B | ||
| Average | 24.83x | 4.32x | 13.09x | 3.5% | 74.89B | |
| Weighted average by Cap. | 19.60x | 6.34x | 14.37x | 4.15% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BATS Stock
- Valuation British American Tobacco p.l.c.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















